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Background
17
Xenoestrogens are a group of endocrine disrupting chemicals (EDCs) that specifically interfere with 18 the endogenous estrogen hormone signaling pathways and/or metabolism [1] . Exposure to 19 xenoestrogens during susceptible developmental stages like the prenatal period has been related to a 20 number of adverse health outcomes in the offspring, both in humans and in animals, including 21 alterations in birth weight, growth and body mass index, male and female reproductive 22 abnormalities, infant neurodevelopment or increased risk for diabetes and several types of cancer 23 among others [2-10]; with evidences for sex-specific associations [10] [11] [12] [13] [14] [15] . 24
The environmental epigenetic hypothesis suggests that the fetal epigenome may be affected by in 25 utero environmental exposures, and this may play a role in later disease phenotypes [16] . The adverse 26 effects of environmental exposures are especially relevant in the context of early exposure to EDCs, 27 since endogenous hormones, active at extremely low concentrations, play critical developmental 28 roles during the prenatal period [17, 18] . Mice models have revealed that in utero exposure to 29 xenoestrogens may disrupt DNA methylation. Bisphenol A and diethylstilbestrol, compounds with 30 known xenoestrogenic properties, induced higher expression of the Enhancer of Zeste Homolog 2 31 gene, a histone methyltransferase which resulted in increased mammary histone H3 trimethylation 32 and triggered methylation changes in several estrogen-responsive genes [19, 20] . In another study, 33 dietary exposure to soy phytoestrogens in pregnant rats advanced sexual maturation and induced 34 aberrant promoter methylation of skeletal α-actin, estrogen receptor-αand c-fos genes in the offspring [21, 35 22] . In addition, the pesticide methoxychlor induced changes in DNA methylation at a number of 36 imprinted genes, accompanied by a substantial decrease in mice sperm count [23] . 37
In humans, significant associations have been reported between prenatal exposure to single 38 xenoestrogens like the persistent organic chemicals dichlorodiphenyltrichloroethane (DDT), 39 dichlorodiphenyldichloroethylene (DDE) or polychlorinated biphenyls (PCBs) and global DNA 40 hypomethylation, measured as DNA methylation in retrotransposon elements (LINEs and SINEs) 41 [14, [24] [25] [26] , as well as at gene-specific level [27] . On the other hand, a recent study has shown that 42 prenatal exposure to phthalates and phenols was related to methylation changes in placenta in the 43 imprinted H19 gene and in the IGF2 differentially methylated region 2 (DMR2) only in boys, two 44 regions known to play a major role in fetal and placental growth, although a further relation with 45 birth weight could not be demonstrated in this study [28] . Epigenetic dysregulation of the placenta, 46 which can be caused by several environmental factors, may lead to abnormal placental development 47 and function [29] . Even if this organ does not form part of an adult, the human placenta plays a key 48 role in ensuring optimal fetal development and growth, with implications for newborns disease 49 predisposition in later life. 50
Exposure during pregnancy to arsenic and cadmium, metals which have been suggested to interfere 51 with estrogen signaling [30] [31] [32] [33] , has been associated to methylation changes in cord blood DNA, 52 both globally and in specific genomic sites as revealed by epigenome-wide association studies 53 (EWAS) [34] , with stronger associations often observed in males [15, [35] [36] [37] . 54
However, exposure to single chemicals is often an unrealistic scenario, since environmental 55 contamination, including EDCs, is rarely due to a single compound but to mixtures to which 56 populations are exposed that may produce additive or even synergistic effects [38] [39] [40] . The use of 57 biomarkers of cumulative exposure, such as the Total Effective Xenoestrogen Burden (TEXB) is 58 therefore a more realistic approach to study the impact of co-exposure to mixtures of chemicals 59 with estrogenic disrupting properties in a real world scenario [41, 42] . 60
61
We previously reported male specific associations between placenta TEXB-alpha and children birth 62 weight, early growth and motor development at age 1-2 [43, 44], accompanied by DNA 63 hypomethylation in Alu retrotransposons in placenta [45] . The aim of the present study is to 64 perform an epigenome-wide association study (EWAS) analyzing boys and girls separately to 65 identify differentially methylated genomic loci in placenta in relation to prenatal TEXB-alpha 66 exposure. 67
68
Material and methods
69
Study population 70
The INMA-INfancia y Medio Ambiente-(Environment and Childhood) Project is a Spanish multi 71 center birth cohort study exploring the role of environmental pollutants on children development 72 and health [46] . All participants involved in the study provided written consent prior to 73 participation, and the research protocol was approved by the Ethical Committees of the Institutions 74 and Centers from the different Spanish regions. 75
Two subsets of samples were analyzed in the current study, one for the discovery step and the 76 other for the replication step. The discovery study included 181 women of Caucasian origin 77 enrolled from November 2003 to January 2008 from four different areas of Spain: Asturias (18%), 78
Basque Country (34%), Catalonia (37%) and Valencia (11%), who had not followed any program of 79 assisted reproduction, gave singleton birth at the reference hospitals and had placenta collected at 80 delivery. In the replication step, 126 women from the same cohort which had male deliveries were 81 selected, enrolled in the study in the same period and following the same inclusion criteria from 82 Asturias (4%), Basque Country (39%), Catalonia (37%) and Valencia (20%). 83
84
Exposure assessment 85
The Total Effective Xenoestrogen Burden (TEXB) is a biomarker of the combined estrogenic 86 effect of environmental estrogens [47] . The detailed procedure has previously been published 87 elsewhere [42, 48] . Briefly, half of each placenta was homogenized, in order to obtain a sample 88 representative of the maternal-fetal unit. Thereafter, an hexane-based solid-liquid extraction method 89 was used to separate less lipophilic chemicals including endogenous hormones (beta fraction) from 90 more lipophilic environmental compounds, i.e. persistent organic pollutants with xenoestrogenic 91 potential (alpha fraction). Then, the estrogenicity of the alpha fraction (i.e. TEXB-alpha) for each 92 placenta sample was quantified using the E-Screen bioassay, a cell proliferation assay using MCF7 93 breast cancer cells, at the Biomedical Research Center from the University of Granada (Spain). 94 TEXB-alpha was expressed in picomolar (pM) estradiol equivalent units (Eeq) per gram of placenta 95 tissue (pM Eeq/g placenta). 96
DNA isolation and methylation genome-wide data generation 97
INMA placentas were stored at -80ºC at the IUSC Biobank of the San Cecilio University Hospital 98 (Granada). Later, half of each sample was homogenized for exposure assessment as described 99 previously, and the other half was partially defrosted and biopsies of 5 cm³ from the inner region of 100 the placenta were conducted, approximately at a distance of 1.0-1.5 cm below the fetal membranes, 101 which were previously removed, and at a distance of ~5 cm from the site of cord insertion, in order 102 to obtain biopsies from the placental villous parenchyma as homogeneous as possible across 103 samples. Twenty five mg of tissue were used for DNA extraction, previously rinsed twice during 5 104 minutes in 0.8 mL of 0.5X PBS in order to remove traces of maternal blood. Genomic DNA from 105 placenta was isolated using the DNeasy® Blood and Tissue Kit (Qiagen, CA, USA) in narrow time 106 windows and by the same person, in order to minimize technical and operator variations. 107 DNA quality was evaluated using a NanoDrop spectrophotometer (Thermo Scientific, Waltham, 108 MA, USA) and additionally 100 ng of DNA were run on 1.3% agarose gels to confirm that samples 109 did not present visual signs of degradation (smears or bands below 10,000 bp). Isolated genomic 110 DNA was stored at -20°C until further processing. 111
Genome-wide DNA methylation was measured in 202 placenta samples (including ten duplicates) 112 using the Illumina Infinium Human Methylation450 BeadChip, a panel which roughly spans 113 486,000 CpG sites in the human genome. Samples were plated on each chip, experimentally 114 randomized with regard to sex distribution and processed blind to sample identification at the 115 Genome Analysis Facility of the University Medical Center Groningen (UMCG) in Holland, 116 where500 ng of good quality DNA was used to perform bisulfite conversion followed by 117 methylation profiling following Illumina's protocol. 118
BeadChips were scanned with an Illumina iScan and image data was uploaded into the Methylation 119
Module of Illumina's analysis software GenomeStudio (lllumina, SanDiego, CA USA), and 120 converted in β-values, that range from 0 (unmethylated) to 1 (fully methylated) and represent the 121 fraction of methylation at a given CpG locus. 122
123
Methylation data quality control and normalization 124
Methylation data quality control (QC) was performed in several steps to exclude low quality 125 samples and probes. 126
First, using the Genome Studio software, we removed samples that did not reach a call rate of 95% 127 at a p-value below 0.05. Then, following Illumina recommendations we verified the intensities of 128 several control probes provided by Illumina in order to: i) assess the quality of the experiment 129 (sample-dependent controls) and ii) identify problems in specific experimental steps (sample-130 independent controls). If a given sample failed in 3 or more Illumina controls, it was excluded from 131 further analyses. Altogether, 2 samples were excluded that did not meet these two criteria. 132
Ten biological duplicates, distributed either in the same or in different bisulfite plates and 133
BeadChips, were used to estimate the discrimination threshold of the Infinium450K Array using 134 the total deviation index (TDI) [49] , which was 0.059 in duplicates from different bisulfite and 135 hybridation arrays, 0.057 in duplicates from the same bisulfite but different hybridation arrays, and 136 0.066 in duplicates both from the same bisulfite and hybridation array. Additionally, the 450K 137
BeadChip features 65 control probes which assay highly-polymorphic single nucleotide 138 polymorphisms (SNPs). Consistent results were observed when we performed pairwise correlations 139 of these genotypes in our duplicates (See Supplementary Figure 1) . After these steps, one of the 140 biological duplicate samples (randomly selected) as well as the 65 SNP probes were removed from 141 the dataset. 142
Methylation patterns in chromosome X probes were used to cluster subjects according to sex by 143 principal component analysis, and 8 mismatched samples were detected in relation to the 144 information on sex contained in our database. These samples were also excluded from further 145
analyses. 146
An additional QC step was performed in R environment using the WateRmelon package [50] , and 1 147 sample presenting more than 1% of sites with a detection p-value greater than 0.05 was excluded, in 148 addition to 1,859 probes, either because they occurred in more than 1% of samples with a p-value 149 greater than 0.05 or because they presented a bead count below 3 in more than >5% of samples. 150
Finally, probes that ambiguously mapped to the human genome with at least 47 base pairs or more 151 (N=29.233) were excluded, and probes containing a SNP with a minor allele frequency (MAF) in 152
HapMap European population (CEU) > 4%, either at the extension site or in the 10 nucleotides 153 immediately before (N=14.122), as suggested by Chen et al. [51] . Probes corresponding to CpG 154 sites located in chromosomes X and Y were also excluded (n=8.537). 155
A total of 433.131 CpG sites on autosomes were tested with regard to TEXB-alpha exposure in the 156 remaining 181 samples, representing 93 boys and 88 girls. Raw methylation beta values were then 157 normalized to reduce technical variability and four different normalization methods were compared 158 (dasen, BMIQ, quantile normalization and Swan) using three performance metrics as proposed by 159 Pidsley et al [52] . Dasen normalization was used for further analyses as it resulted the best ranked 160 method in our data (Additional information in Supplemental Material and Methods). 161
Epigenome-Wide Association Study 162
A robust linear regression model was employed using MASS (R package), to test the association 163 between doubling of TEXB-alpha concentration and methylation at each CpG site in boys and in 164 girls separately. Analyses were adjusted for area of study and two technical factors: chip and 165
CpG sites annotation 171
In order to obtain information on the top differentially methylated CpG sites in our study the 172 University of California, Santa Cruz (UCSC) Genome Browser interface was used, which in The association between doubling the concentration of TEXB-alpha and changes in DNA 192 methylation was tested using adjusted linear mixed regression models including repeated 193 measurements (pyrosequencing duplicates) as random intercept. 194
Results
195
Study population characteristics 196
Overall, our discovery study population did not differ from the rest of INMA cohort participants 197 for the main pregnancy related and socio-demographic characteristics Women in the discovery 198 study were on average 32 years old, with a pre-pregnancy BMI of 23.45 kg/m². Only 3 children 199 were born preterm, which represented a slightly lower (non-significant) percentage than what we 200 observed in the rest of the INMA cohort participants and, concordantly, we saw less small for 201 gestational age (SGA) children in our discovery study group when compared to the rest of INMA 202 cohort (p-value<0.02) (Supplementary Material and Methods, Table 2 ). Additionally, no significant 203 differences were observed for any of the maternal and infant sociodemographic and pregnancy 204 related characteristics when comparing the discovery and replication populations used in our study, 205 as shown in Table 1 LGA: above the 90th percentile of birth weight, adjusted for sex and gestational age. 4 Only boys were included in the replication study.
Association of TEXB-alpha and genome-wide DNA methylation in placenta 1
No epigenome-wide significant associations were found either in boys or in girls between each 2 doubling of TEXB-alpha (pM Eeq/g placenta) and methylation at CpG sites in placenta after 3 correcting for multiple testing. Results for the 12 most significant CpG sites in boys (n=93) and in 4 girls (n=88) are presented in Table 2 . Quantile-quantile (Q-Q) plots showing the observed versus 5 expected -log10 (P-values) under the null hypothesis of no association are shown in Supplementary 6 Figure 3 . Among the top CpG sites differentially methylated in boys we found some genes 7 previously related to growth and steroid hormone signaling, while none of these genes were 8 observed in girls (See Supplementary Materials and Methods, Table 3 for additional information). 9 
14 Validation and replication of selected top CpGs in boys 15
Two CpGs differentially methylated in relation to TEXB-alpha in boys were selected for further 16 validation by pyrosequencing in the same samples (n=92) and replication was conducted in 17 additional 126 placenta samples from male deliveries. 18
The first CpG, the top differentially methylated cg05342136 in boys, is located in the exon 1 of the 19 low density lipoprotein receptor-related protein associated protein 1(LRPAP1), a lipid-metabolism 20 gene highly expressed in placenta that in turn interacts with TGFb1, an angiogenic factor mediating 21 successful placentation and fetal growth via regulation of trophoblast invasion, cell differentiation, 22 immunosuppression and apoptosis of vascular endothelial cells, which has also been associated with 23 susceptibility to degenerative dementia [57-60]. The second selected CpG site, cg15809858, is 24 located in the first intron of Homo Sapiens peroxisome proliferator-activated receptor gamma, 25 coactivator 1 beta (PPARGC1B), a gene expressed in human placenta that stimulates the activity of 26 several transcription factors and nuclear receptors, including estrogen receptor alpha, nuclear 27 respiratory factor 1, and glucocorticoid receptor, shown to be down regulated in pre-diabetic and 28 type 2 diabetes mellitus patients and previously related to an increased risk of developing obesity 29
Results from the discovery EWAS could not be neither validated nor replicated for the two CpG 31 sites analyzed (Table 3) , although a trend for technical validation (i.e. we were able to confirm the 32 magnitude and the direction of the effect) was observed for cg05342136 (β=0.29 in the discovery vs 33 β=0.25 in the validation study). Scatter plots showing the correlation between DNA methylation 34 values measured using the Illumina 450K array platform and by bisulfite pyrosequencing in the 35 same samples (discovery) are shown for cg05342136 and cg15809858 in Supplementary Material 36 and Methods, Figure 4 . 37 
Discussion
44
This is the first genome-wide study analyzing site-specific DNA methylation changes in placenta 45 tissue in relation to a biomarker of exposure to mixtures of environmental estrogens. At the 46 interface between mother and child, the human placenta is an organ involved in the regulation of 47 fetal growth and development and represents a gateway for substances, including xenoestrogens, to 48 enter fetal circulation [64, 65] . 49
In the INMA cohort we previously reported sex-specific associations between the TEXB-alpha 50 biomarker measured in placenta and birth weight changes in boys only [48] , along with lower 51
AluYb8 retrotransposon methylation in placental DNA in the same group, used as a surrogate to 52 study global genomic DNA methylation [45] . In order to gain further mechanistic insight into these 53 associations, we have performed an EWAS study in placenta, stratifying data by sex, to identify 54 differentially methylated genes as a result of prenatal exposure to xenoestrogens. No genome-wide 55 significant associations were found between each doubling of TEXB-alpha and DNA methylation 56 after correcting for multiple testing in either group. However, among the top significant CpG sites 57 differentially methylated in relation to each doubling of TEXB-alpha in boys, several were located 58 in genes that have been related to birth weight regulation, type 2 diabetes and obesity risk or steroid 59 hormone metabolism, and are known to be expressed in human placenta tissue. The top significant 60 one, cg05342136, is located in the first exon of LRPAP1), a gene involved in cholesterol 61 metabolism, the primary metabolite of steroid hormone synthesis [66] . We also found an increase in 62 DNA methylation in cg15809858, located in exon 1 of PPARGC1B. The protein encoded by this 63 ubiquitously expressed gene stimulates the activity of several transcription factors and nuclear 64 receptors, including estrogen receptor alpha (ERα), and may be involved in fat oxidation, non-65 oxidative glucose metabolism, and the regulation of energy expenditure. This protein is down-66 expressed in pre-diabetic and type 2 diabetes mellitus patients and certain allelic variations in this 67 gene increase the risk of the development of obesity, type 2 diabetes and breast cancer [61, 67] . Overall, although statistically non-significant, these findings seem to go in line with our previous 79 results, showing that higher levels of xenoestrogens (TEXB-alpha) measured in placenta were 80 associated with higher birth weight in boys (on average 148 grams when comparing high versus low 81 exposed children), while no effects were found in girls [48] . However, we could not validate neither 82 replicate our initial findings for two selected CpGs, and only for cg05342136, technical verification 83 showed a coefficient (β value) of the same magnitude and direction as in the discovery study. In our 84 data, we observe a poor reproducibility between DNA methylation values measured using the 450K 85 Illumina array platform and by bisulfite pyrosequencing in the same samples, especially when CpGs 86 are hypomethylated (as for cg15809858). Whether this lack of technical replication and biological 87 validation of the results in our study reflects differences in the reproducibility, specificity and/or 88 measurement sensitivity across different platforms used to measure DNA methylation (i.e. potentially important genomic regions in our study. 98
Our study has two main methodological strengths: first, exposure to mixtures of xenoestrogens was 99 measured in placenta tissue using a biomarker, and second DNA methylation changes were 100 analyzed in the same tissue, which is relevant considering the tissue specificity of epigenetic marks, 101 the role of this organ during prenatal development and its sensitivity to the effects of hormones 102 [74] . 103
The magnitude of the differences in DNA methylation that we observed was small, although 104 similar to what has been previously shown in other EWAS in relation to prenatal exposure to other 105 environmental chemicals, including potential xenoestrogens like cadmium [75] . To some extent, our 106 results may have been confounded by cell type mixtures in placenta samples, or by the possible 107 maternal cell contamination, which in both cases could have led to a possible underestimation of 108 the effects, while we do not know whether the observed changes in DNA methylation have 109 functional effects on gene expression, since RNA was degraded due to placenta collection 110 conditions in our cohort. Only one biopsy for DNA extraction was conducted per sample, which 111 could have introduced additional noise due to regional variations in DNA methylation, although 112 some authors have suggested that this is not a major source of DNA methylation variation in 113 human placenta [76] . Finally, some uncertainty exists on whether the TEXB-alpha biomarker, based 114 on a lipophilic extraction of compounds (excluding endogenous steroid hormones and more polar 115 xenoestrogens) followed by a quantification of MCF7 cell proliferation assay, is exclusively a 116 biomarker of xenoestrogenicity, or also a biomarker of other lipophilic compounds present in the 117 placenta that activate growth, and that might not necessarily (or uniquely) act through binding or 118 interacting with the estrogen receptor. 119
Conclusion
120
We conducted a genome-wide methylation study in placental tissue in relation to prenatal exposure 121 to mixtures of xenoestrogens using the TEXB-alpha biomarker, and although we identified some 122
suggesting genes differentially methylated in boys, we were not able to validate neither replicate our 123 initial findings by pyrosequencing. Future studies are warranted to confirm the observed 124 associations and their potential to mediate the effect of prenatal exposure to mixtures of endocrine 125 disruptors on the offspring's health. 126 127
